Georgina is an investment analyst at Hadean Ventures. Her academic background is in molecular biology, from University College London (UCL) and University of Oslo. During her PhD she focussed on animal models and biomarkers for Huntington’s Disease and published several peer-reviewed scientific articles on the subject.
Georgina has worked across life science areas, from scientific publishing to consulting and public funding mechanisms. She has a unique insight into Norwegian life science start-ups and government innovation and development initiatives.